Gaithersburg, MD – October 9, 2018 – U.S. based Institute for In Vitro Sciences (IIVS) has been invited by China’s National Institute for Food and Drug Control (NIFDC) to join their working group on alternatives for cosmetics. The newly established group was announced by the NIFDC during their 2nd International Conference on Cosmetics Alternative Methods held in Beijing in September. Chaired by NIFDC Vice Director, Lu Yong, the working group also includes representatives from several provincial government agencies and companies such as Estée Lauder, Procter & Gamble and Clarins.
“IIVS has a long-standing partnership with the NIFDC to help them incorporate alternatives into their regulatory oversight of cosmetics” said Erin Hill, President of IIVS. “The establishment of this working group clearly demonstrates the NIFDC’s commitment to alternatives and we are proud to be considered among their top advisors.”
The working group will advise on research and validation efforts to help establish alternatives to animal tests in China. IIVS, a world renowned leader in the validation and implementation of alternative methods, has been working directly with the NIFDC to help build the infrastructure in China that they require before more alternative methods can be accepted. IIVS was heavily involved in the review of the first alternative method accepted by China’s Food and Drug Administration in 2016 and has recently advised on 2 other methods currently under review. Earlier this year IIVS collaborated with the world’s leading chemical company BASF SE to import a cell based assay for skin sensitization into China for the NIFDC.
About the Institute for In Vitro Sciences (IIVS)
IIVS is a non-profit organization wholly dedicated to the promotion of rapid and innovative non-animal test methods. Founded in 1997, IIVS is recognized as a leading provider of in vitro testing in support of toxicological safety evaluations. Rigorous scientific programs coupled with educational and outreach initiatives have established IIVS as a global leader in the advancement of alternatives to animal testing.